Gray-zone commerce: pricing the loophole.
The fastest-growing categories in consumer are fast precisely because they’re legally unfinished. Hemp THC drinks went $239M to $1.1B+ in two years; nicotine pouches, kratom, peptide wellness, and ketamine-adjacent telehealth all ran similar curves. Each one is a market where demand arrived before the rules did — which means margin without incumbents, and a clock you can’t see. After watching the hemp beverage category get unwound by an appropriations rider, we built a framework for underwriting these “gray-zone” categories. This is it.
- Gray-zone categories share one structure: a definitional gap (hemp vs marijuana, “tobacco-free” nicotine, “research” peptides) creates a legal product no incumbent will touch — yet.
- The economics are seductive: no entrenched competition, performance channels open, retail hungry for novelty, customers underserved.
- The risk is not gradual: regulation arrives as step-functions — a rider, an emergency reg, an enforcement letter — and the November 2025 hemp cap proved it can come through must-pass bills nobody can lobby.
- Our rule: value loophole-dependent revenue as an option, not a cash flow — and only operate in gray zones with an explicit exit ramp into a durable category.
The anatomy of a gray zone
Every recent example follows the same lifecycle. Phase 1, the gap opens: a statute defines a banned thing precisely, and chemistry or commerce finds the adjacent legal thing (delta-9 by dry weight; synthetic nicotine when the FDA’s tobacco authority covered only tobacco-derived; compounded GLP-1s during shortage declarations). Phase 2, the operators arrive: usually performance marketers, because the gap’s biggest gift is channel access incumbents don’t have. Phase 3, the category professionalizes: retail doors, coalitions, self-imposed testing standards — the responsible actors genuinely try to become a regulated industry. Phase 4, the correction: and here’s the asymmetry — the correction is written by whoever has the strongest lobby in the room, which is never the startups. Licensed marijuana wanted hemp THC gone as much as prohibitionists did. Pharma wants compounded GLP-1s gone. Big Tobacco bought the largest pouch brand and then welcomed the regulation that drowns its small competitors.
Underwriting the clock
The discipline is to price the three questions nobody wants to answer during the gold rush. One: who profits from closing the gap? If an incumbent industry with permanent lobbyists benefits from your extinction, your timeline is their legislative calendar. Two: what vehicle closes it? Standalone bills are slow and survivable; emergency regulations and appropriations riders are not — hemp’s 0.4mg cap rode a shutdown-ending bill that no targeted opposition could stop. Three: what survives the correction? This is the only question that creates value. An email list, a brand meaning, a retail relationship, a manufacturing capability — assets that port into the post-correction category (or a neighboring durable one) are the real equity; everything else is terminal-value-zero cash flow that must pay itself back fast.
In a gray zone, your true competitors are not other brands. They are legislators — and they ship on their own schedule, in vehicles you cannot block.
The option-pricing rule
Practically, we model gray-zone revenue with three adjustments. Payback ceilings: every dollar deployed must return inside the shortest plausible regulatory window — for hemp THC after September 2024, that was under 18 months, which is why the smart operators ran profitable and hoarded list. Terminal value haircuts: exit multiples assume the category as-is does not exist at exit; anything better is upside. Optionality premiums: we pay extra only for the portable assets — audience, brand elasticity, formulation IP, compliance muscle. Run BREZ through this lens and the verdict is precise: phenomenal operating company, correctly built (profitable fast, subscription-heavy, owned-channel rich), in an asset class where the equity was always an option. The operators who treated it that way will land fine. The ones who priced it as a perpetuity financed a countdown.
| Signal | Green (durable) | Red (optional) |
|---|---|---|
| Legal basis | Explicitly permitted | Definitional gap |
| Incumbent lobby | None / aligned | Benefits from your extinction |
| Closure vehicle | Slow rulemaking | Riders, emergency regs |
| Portable assets | Brand, list, retail, IP | Loophole-only margin |
| Our posture | Underwrite normally | Option pricing or pass |
- We don’t categorically avoid emerging categories — we categorically refuse to price them as durable ones.
- Acquisition targets emerging from a gray zone (audience intact, category reset) can be exceptional buys: the correction does our price negotiation for us.
- Every LAMPWORK brand carries a standing “regulatory floor” memo: what law, if changed, breaks the model — and what ports if it does.
Sources: Axios: hemp rider in shutdown bill; Arnold & Porter; Whitney Economics; Beverage Industry / Euromonitor; FDA on compounded GLP-1s; NPR; Baker Institute state tracker; companion piece: BREZ: A Rocket on Rented Ground.
Own a brand this applies to?
We talk to founders at every stage — long before they're ready to sell.
Start a Conversation →